MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial - Concepedia

Concepedia

Publication | Open Access

MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial

DOI Full Paper Access

80

Citations

39

References

2014

Year

Emanuela Romano, Olivier Michielin, Verena Voelter, Julien Laurent, Hélène Bichat, Athina Stravodimou, Pedro Romero, Daniel E. Speiser, Frédéric Triebel, Serge Leyvraz,

Journal of Translational Medicine

References

	Year	Citations

Page 1